CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tebuconazole
Accession: CHEBI:81781
browse the term
Definition: A racemate composed of equimolar amounts of (R)- and (S)-tebuconazole. A fungicide effective against various smut and bunt diseases in cereals and other field crops.
Synonyms: exact_synonym: rac-1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol
related_synonym: (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol; Ethyltrianol; Fenetrazole; Terbuconazole
alt_id: CHEBI:83566
xref: CAS:107534-96-3; KEGG:C18489
xref_mesh: MESH:C087114
xref: PMID:24200952; PMID:24522828; PMID:24920897; PMID:25300182; Pesticides:tebuconazole; Reaxys:6686475; Wikipedia:Tebuconazole
G
A2ml1
alpha-2-macroglobulin-like 1
decreases expression
ISO
tebuconazole results in decreased expression of OVOS2 mRNA
CTD
PMID:30458266
NCBI chr 4:163,501,210...163,543,419
Ensembl chr 4:163,501,585...163,543,506
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
tebuconazole promotes the reaction [propiconazole results in decreased expression of ABCB11 mRNA] tebuconazole results in decreased activity of ABCB11 protein
CTD
PMID:36291160
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Abcc3
ATP binding cassette subfamily C member 3
decreases expression
ISO
tebuconazole results in decreased expression of ABCC3 mRNA
CTD
PMID:36291160
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
G
Abcg1
ATP binding cassette subfamily G member 1
decreases expression
ISO
tebuconazole results in decreased expression of ABCG1 mRNA
CTD
PMID:30458266
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression
ISO
tebuconazole results in decreased expression of ABCG5 mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
decreases expression
ISO
tebuconazole results in decreased expression of ABO mRNA
CTD
PMID:30458266
NCBI chr 3:30,560,172...30,604,758
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
ISO
tebuconazole results in increased expression of ACAT2 mRNA
CTD
PMID:36291160
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
G
Acer2
alkaline ceramidase 2
decreases expression
ISO
tebuconazole results in decreased expression of ACER2 mRNA
CTD
PMID:30458266
NCBI chr 5:106,437,773...106,488,572
Ensembl chr 5:106,437,796...106,488,583
G
Acot11
acyl-CoA thioesterase 11
decreases expression
ISO
tebuconazole results in decreased expression of ACOT11 mRNA
CTD
PMID:30458266
NCBI chr 5:126,756,255...126,804,526
Ensembl chr 5:126,756,255...126,804,507
G
Acox1
acyl-CoA oxidase 1
decreases expression multiple interactions
ISO
tebuconazole results in decreased expression of ACOX1 mRNA [propiconazole co-treated with tebuconazole] results in decreased expression of ACOX1 mRNA; [tebuconazole co-treated with fludioxonil] results in decreased expression of ACOX1 mRNA
CTD
PMID:30989312 PMID:33575850
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
G
Acss1
acyl-CoA synthetase short-chain family member 1
decreases expression
ISO
tebuconazole results in decreased expression of ACSS1 mRNA
CTD
PMID:30458266
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748
G
Actl7a
actin-like 7a
decreases expression
ISO
tebuconazole results in decreased expression of ACTL7A mRNA
CTD
PMID:30458266
NCBI chr 5:76,242,201...76,245,647
Ensembl chr 5:76,240,427...76,247,023
G
Adamts19
ADAM metallopeptidase with thrombospondin type 1 motif, 19
decreases expression
ISO
tebuconazole results in decreased expression of ADAMTS19 mRNA
CTD
PMID:30458266
NCBI chr18:54,545,357...54,729,184
Ensembl chr18:54,545,357...54,729,181
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
ISO
tebuconazole results in decreased expression of ADH4 mRNA
CTD
PMID:30458266
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]
CTD
PMID:30458266
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Akap5
A-kinase anchoring protein 5
decreases expression
ISO
tebuconazole results in decreased expression of AKAP5 mRNA
CTD
PMID:30458266
NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620
G
Aknad1
AKNA domain containing 1
decreases expression
ISO
tebuconazole results in decreased expression of AKNAD1 mRNA
CTD
PMID:30458266
NCBI chr 2:199,076,864...199,120,402
Ensembl chr 2:199,081,596...199,120,375
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression multiple interactions
ISO
tebuconazole results in increased expression of AKR1B10 mRNA [propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA
CTD
PMID:30989312
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
decreases expression
ISO
tebuconazole results in decreased expression of ALDH1A3 mRNA
CTD
PMID:30458266
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
tebuconazole results in decreased expression of ALDOB mRNA
CTD
PMID:30458266
NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740
G
Amotl1
angiomotin-like 1
decreases expression
ISO
tebuconazole results in decreased expression of AMOTL1 mRNA
CTD
PMID:30458266
NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:19,634,510...19,748,869
G
Ankrd61
ankyrin repeat domain 61
decreases expression
ISO
tebuconazole results in decreased expression of ANKRD61 mRNA
CTD
PMID:30458266
NCBI chr12:15,832,567...15,836,925
Ensembl chr12:15,832,108...15,836,923
G
Anxa10
annexin A10
increases expression
ISO
tebuconazole results in increased expression of ANXA10 mRNA
CTD
PMID:32194361
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
tebuconazole results in decreased expression of APELA mRNA
CTD
PMID:30458266
NCBI chr16:29,460,855...29,469,962
Ensembl chr16:29,460,812...29,469,955
G
Apoa4
apolipoprotein A4
decreases expression
ISO
tebuconazole results in decreased expression of APOA4 mRNA
CTD
PMID:30458266
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
G
Apof
apolipoprotein F
decreases expression
ISO
tebuconazole results in decreased expression of APOF mRNA
CTD
PMID:30458266
NCBI chr 7:1,285,222...1,286,659
Ensembl chr 7:1,285,222...1,286,659
G
Aqp1
aquaporin 1
increases expression
EXP
tebuconazole results in increased expression of AQP1 mRNA
CTD
PMID:33049508
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
G
Ar
androgen receptor
multiple interactions
ISO
[propiconazole co-treated with prochloraz co-treated with tebuconazole] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; [tebuconazole co-treated with prochloraz] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; tebuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tebuconazole inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; tebuconazole inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; tebuconazole inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785 PMID:21310686 PMID:26602169 PMID:33049310
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
G
Arg1
arginase 1
decreases expression
ISO
tebuconazole results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
G
Atoh8
atonal bHLH transcription factor 8
decreases expression
ISO
tebuconazole results in decreased expression of ATOH8 mRNA
CTD
PMID:30458266
NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379
G
Atp1a2
ATPase Na+/K+ transporting subunit alpha 2
increases expression
EXP
tebuconazole results in increased expression of ATP1A2 mRNA
CTD
PMID:28970091
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911
G
Atp2b3
ATPase plasma membrane Ca2+ transporting 3
decreases expression
ISO
tebuconazole results in decreased expression of ATP2B3 mRNA
CTD
PMID:30458266
NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153
G
Atxn7l1
ataxin 7-like 1
decreases expression
ISO
tebuconazole results in decreased expression of ATXN7L1 mRNA
CTD
PMID:30458266
NCBI chr 6:55,487,309...55,709,751
Ensembl chr 6:55,649,362...55,701,996
G
Basp1
brain abundant, membrane attached signal protein 1
decreases expression
ISO
tebuconazole results in decreased expression of BASP1 mRNA
CTD
PMID:30458266
NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO EXP
tebuconazole results in increased expression of BAX protein
CTD
PMID:26852204 PMID:32735800
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO EXP
tebuconazole results in decreased expression of BCL2 protein
CTD
PMID:26852204 PMID:32735800
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bicra
BRD4 interacting chromatin remodeling complex associated protein
decreases expression
ISO
tebuconazole results in decreased expression of BICRA mRNA
CTD
PMID:30458266
NCBI chr 1:85,790,093...85,867,656
Ensembl chr 1:85,790,093...85,864,306
G
Bpi
bactericidal/permeability-increasing protein
decreases expression
ISO
tebuconazole results in decreased expression of BPI mRNA
CTD
PMID:30458266
NCBI chr 3:167,329,513...167,356,217
Ensembl chr 3:167,329,530...167,356,396
G
C10h16orf90
similar to human chromosome 16 open reading frame 90
decreases expression
ISO
tebuconazole results in decreased expression of C16ORF90 mRNA
CTD
PMID:30458266
NCBI chr10:12,125,235...12,138,441
Ensembl chr10:12,125,212...12,128,109
G
C18h18orf63
similar to human chromosome 18 open reading frame 63
increases expression
ISO
tebuconazole results in increased expression of C18ORF63 mRNA
CTD
PMID:30458266
NCBI chr18:80,434,363...80,477,235
Ensembl chr18:80,392,056...80,477,189
G
C3h9orf50
similar to human chromosome 9 open reading frame 50
decreases expression
ISO
tebuconazole results in decreased expression of C9ORF50 mRNA
CTD
PMID:30458266
NCBI chr 3:34,477,535...34,484,791
Ensembl chr 3:34,478,508...34,484,805
G
C4h3orf22
similar to human chromosome 3 open reading frame 22
decreases expression
ISO
tebuconazole results in decreased expression of C3ORF22 mRNA
CTD
PMID:30458266
NCBI chr 4:124,374,885...124,379,380
Ensembl chr 4:124,375,807...124,379,379
G
C9
complement C9
decreases expression
ISO
tebuconazole results in decreased expression of C9 mRNA
CTD
PMID:30458266
NCBI chr 2:57,300,510...57,348,759
Ensembl chr 2:57,300,427...57,348,752
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
decreases expression
ISO
tebuconazole results in decreased expression of CACNA1D mRNA
CTD
PMID:30458266
NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692
G
Carmn
cardiac mesoderm enhancer-associated non-coding RNA
decreases expression
ISO
tebuconazole results in decreased expression of CARMN mRNA
CTD
PMID:30458266
NCBI chr18:57,368,191...57,389,112
Ensembl chr18:57,360,134...57,389,921
G
Casp3
caspase 3
increases cleavage
EXP
tebuconazole results in increased cleavage of CASP3 protein
CTD
PMID:32735800
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cat
catalase
increases activity
EXP
tebuconazole results in increased activity of CAT protein
CTD
PMID:29923317 PMID:32735800
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Ccdc168
coiled-coil domain containing 168
decreases expression
ISO
tebuconazole results in decreased expression of CCDC168 mRNA
CTD
PMID:30458266
NCBI chr 9:53,690,704...53,728,801
Ensembl chr 9:53,690,786...53,727,639
G
Cd28
Cd28 molecule
decreases expression
ISO
tebuconazole results in decreased expression of CD28 mRNA
CTD
PMID:30458266
NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192
G
Cd34
CD34 molecule
increases expression
EXP
tebuconazole results in increased expression of CD34 mRNA; tebuconazole results in increased expression of CD34 protein
CTD
PMID:33049508
NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315
G
Cd36
CD36 molecule
decreases expression multiple interactions increases expression
ISO EXP
tebuconazole results in decreased expression of CD36 mRNA [propiconazole co-treated with tebuconazole] results in decreased expression of CD36 mRNA tebuconazole results in increased expression of CD36 mRNA; tebuconazole results in increased expression of CD36 protein
CTD
PMID:30989312 PMID:33049508
NCBI chr 4:18,209,088...18,302,142
G
Cdh23
cadherin-related 23
decreases expression
ISO
tebuconazole results in decreased expression of CDH23 mRNA
CTD
PMID:30458266
NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332
G
Cfap276
cilia and flagella associated protein 276
decreases expression
ISO
tebuconazole results in decreased expression of CFAP276 mRNA
CTD
PMID:30458266
NCBI chr 2:198,854,129...198,871,406
Ensembl chr 2:198,854,129...198,866,036
G
Cfap58
cilia and flagella associated protein 58
decreases expression
ISO
tebuconazole results in decreased expression of CFAP58 mRNA
CTD
PMID:30458266
NCBI chr 1:256,743,971...256,852,633
Ensembl chr 1:256,743,971...256,852,623
G
Cfap61
cilia and flagella associated protein 61
decreases expression
ISO
tebuconazole results in decreased expression of CFAP61 mRNA
CTD
PMID:30458266
NCBI chr 3:153,807,672...154,086,591
Ensembl chr 3:153,807,735...154,086,590
G
Cfap97d1
CFAP97 domain containing 1
decreases expression
ISO
tebuconazole results in decreased expression of CFAP97D1 mRNA
CTD
PMID:30458266
NCBI chr10:87,432,559...87,444,711
Ensembl chr10:87,434,008...87,441,577
G
Cga
glycoprotein hormones, alpha polypeptide
decreases expression
ISO
tebuconazole results in decreased expression of CGA mRNA
CTD
PMID:26852204
NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464
G
Cgref1
cell growth regulator with EF hand domain 1
decreases expression
ISO
tebuconazole results in decreased expression of CGREF1 mRNA
CTD
PMID:30458266
NCBI chr 6:31,151,795...31,163,801
Ensembl chr 6:31,151,795...31,163,800
G
Chst13
carbohydrate sulfotransferase 13
decreases expression
ISO
tebuconazole results in decreased expression of CHST13 mRNA
CTD
PMID:30458266
NCBI chr 4:124,381,226...124,395,143
Ensembl chr 4:124,381,226...124,395,143
G
Clec2d
C-type lectin domain family 2, member D
decreases expression
ISO
tebuconazole results in decreased expression of CLEC2D mRNA
CTD
PMID:30458266
NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587
G
Cox4i2
cytochrome c oxidase subunit 4i2
decreases expression
ISO
tebuconazole results in decreased expression of COX4I2 mRNA
CTD
PMID:30458266
NCBI chr 3:161,686,193...161,699,605
Ensembl chr 3:161,689,017...161,699,602
G
Crabp1
cellular retinoic acid binding protein 1
decreases expression
ISO
tebuconazole results in decreased expression of CRABP1 mRNA
CTD
PMID:30458266
NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470
G
Crhr1
corticotropin releasing hormone receptor 1
decreases expression
ISO
tebuconazole results in decreased expression of CRHR1 mRNA
CTD
PMID:30458266
NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466
G
Crppa
CDP-L-ribitol pyrophosphorylase A
increases expression
ISO
tebuconazole results in increased expression of CRPPA mRNA
CTD
PMID:30458266
NCBI chr 6:58,847,550...59,124,309
Ensembl chr 6:58,848,621...59,181,406
G
Cryba2
crystallin, beta A2
decreases expression
ISO
tebuconazole results in decreased expression of CRYBA2 mRNA
CTD
PMID:30458266
NCBI chr 9:83,895,921...83,906,651
Ensembl chr 9:83,895,922...83,899,131
G
Cryga
crystallin, gamma A
decreases expression
ISO
tebuconazole results in decreased expression of CRYGA mRNA
CTD
PMID:30458266
NCBI chr 9:73,975,914...74,006,614
Ensembl chr 9:73,975,914...74,003,290
G
Crygd
crystallin, gamma D
decreases expression
ISO
tebuconazole results in decreased expression of CRYGD mRNA
CTD
PMID:30458266
NCBI chr 9:73,935,798...73,937,409
Ensembl chr 9:73,935,795...73,937,808
G
Csmd2
CUB and Sushi multiple domains 2
decreases expression
ISO
tebuconazole results in decreased expression of CSMD2 mRNA
CTD
PMID:30458266
NCBI chr 5:145,626,823...146,196,815
Ensembl chr 5:145,626,845...146,196,812
G
Cspg4
chondroitin sulfate proteoglycan 4
decreases expression
ISO
tebuconazole results in decreased expression of CSPG4 mRNA
CTD
PMID:30458266
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
G
Ctnna3
catenin alpha 3
decreases expression
ISO
tebuconazole results in decreased expression of CTNNA3 mRNA
CTD
PMID:30458266
NCBI chr20:23,613,016...25,198,699
Ensembl chr20:23,613,016...25,198,805
G
Cyba
cytochrome b-245 alpha chain
increases expression
ISO
tebuconazole results in increased expression of CYBA mRNA
CTD
PMID:30458266
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
tebuconazole results in decreased activity of CYP19A1 protein
CTD
PMID:12127262
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity multiple interactions increases expression
ISO EXP
tebuconazole results in increased activity of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; [propiconazole co-treated with tebuconazole] results in increased expression of CYP1A1 mRNA; [tebuconazole co-treated with fludioxonil] results in increased expression of CYP1A1 mRNA; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; tebuconazole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] tebuconazole results in increased expression of CYP1A1 mRNA; tebuconazole results in increased expression of CYP1A1 protein
CTD
PMID:19070657 PMID:25233012 PMID:29923317 PMID:30458266 PMID:32194361 PMID:33049508 PMID:33575850 More...
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression increases activity
ISO EXP
NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]; [propiconazole co-treated with tebuconazole] results in increased activity of CYP1A2 protein; [propiconazole co-treated with tebuconazole] results in increased expression of CYP1A2 mRNA; [tebuconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] tebuconazole results in increased expression of CYP1A2 mRNA; tebuconazole results in increased expression of CYP1A2 protein tebuconazole results in increased activity of CYP1A2 protein
CTD
PMID:25656644 PMID:29923317 PMID:30458266 PMID:33575850
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
EXP
tebuconazole results in increased expression of CYP26A1 mRNA
CTD
PMID:28970091
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
tebuconazole results in increased expression of CYP2B1 protein
CTD
PMID:29923317
NCBI chr 1:90,646,098...90,669,762
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
tebuconazole results in increased expression of CYP2B2 protein
CTD
PMID:29923317
NCBI chr 1:90,722,243...90,736,272
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression multiple interactions
ISO
tebuconazole results in increased expression of CYP2B6 mRNA [tebuconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA]
CTD
PMID:25656644 PMID:30458266 PMID:33575850
NCBI chr 1:90,780,468...90,859,852
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression increases expression
ISO EXP
tebuconazole results in decreased expression of CYP2E1 mRNA tebuconazole results in increased expression of CYP2E1 protein
CTD
PMID:29923317 PMID:30458266
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP2R1 mRNA
CTD
PMID:30458266
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
increases expression
ISO
tebuconazole results in increased expression of CYP3A43 mRNA
CTD
PMID:30458266
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression decreases activity
ISO
[Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated with prochloraz co-treated with propiconazole co-treated with tebuconazole] results in increased expression of CYP3A4 protein; [tebuconazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA tebuconazole results in increased expression of CYP3A4 mRNA tebuconazole results in decreased activity of CYP3A4 protein
CTD
PMID:29420809 PMID:30458266 PMID:33575850 PMID:34273450 PMID:37422065
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Cyp46a1
cytochrome P450, family 46, subfamily a, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP46A1 mRNA
CTD
PMID:30458266
NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971
G
Cyp51
cytochrome P450, family 51
decreases activity increases expression
ISO
tebuconazole results in decreased activity of CYP51A1 protein tebuconazole results in increased expression of CYP51 mRNA
CTD
PMID:16989930 PMID:29337257
NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP7A1 mRNA
CTD
PMID:30458266 PMID:32194361 PMID:36291160
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP8B1 mRNA
CTD
PMID:36291160
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
ISO
tebuconazole results in decreased expression of DDR2 mRNA
CTD
PMID:30458266
NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288
G
Derl3
derlin 3
decreases expression
ISO
tebuconazole results in decreased expression of DERL3 mRNA
CTD
PMID:30458266
NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477
G
Dnaaf19
dynein axonemal assembly factor 19
decreases expression
ISO
tebuconazole results in decreased expression of DNAAF19 mRNA
CTD
PMID:30458266
NCBI chr10:88,346,453...88,349,853
Ensembl chr10:88,346,453...88,349,853
G
Dnah12
dynein, axonemal, heavy chain 12
increases expression
ISO
tebuconazole results in increased expression of DNAH12 mRNA
CTD
PMID:30458266
NCBI chr16:1,932,776...2,099,391
Ensembl chr16:1,944,752...2,099,373
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
tebuconazole results in decreased expression of DNMT3L mRNA
CTD
PMID:30458266
NCBI chr20:10,614,591...10,628,989
Ensembl chr20:10,614,591...10,629,168
G
Drgx
dorsal root ganglia homeobox
decreases expression
ISO
tebuconazole results in decreased expression of DRGX mRNA
CTD
PMID:30458266
NCBI chr16:7,861,024...7,891,607
Ensembl chr16:7,861,157...7,906,904
G
Dusp2
dual specificity phosphatase 2
decreases expression
ISO
tebuconazole results in decreased expression of DUSP2 mRNA
CTD
PMID:30458266
NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809
G
Dux4
double homeobox 4
decreases expression
ISO
tebuconazole results in decreased expression of DUX4 mRNA
CTD
PMID:30458266
NCBI chr16:1,565,290...1,575,317
Ensembl chr16:1,567,553...1,575,468
G
Egflam
EGF-like, fibronectin type III and laminin G domains
decreases expression
ISO
tebuconazole results in decreased expression of EGFLAM mRNA
CTD
PMID:30458266
NCBI chr 2:58,029,934...58,204,010
Ensembl chr 2:58,029,935...58,203,643
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
EXP
tebuconazole results in decreased expression of EIF2AK2 mRNA; tebuconazole results in decreased expression of EIF2AK2 protein
CTD
PMID:33049508
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116
G
Esr1
estrogen receptor 1
multiple interactions
ISO
tebuconazole binds to and results in increased activity of ESR1 protein
CTD
PMID:33049310
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
G
Esrra
estrogen related receptor, alpha
increases expression
EXP
tebuconazole results in increased expression of ESRRA mRNA; tebuconazole results in increased expression of ESRRA protein
CTD
PMID:33049508
NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811
G
F13a1
coagulation factor XIII A1 chain
decreases expression
ISO
tebuconazole results in decreased expression of F13A1 mRNA
CTD
PMID:30458266
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
G
Fam181a
family with sequence similarity 181, member A
decreases expression
ISO
tebuconazole results in decreased expression of FAM181A mRNA
CTD
PMID:30458266
NCBI chr 6:128,230,171...128,236,193
Ensembl chr 6:128,232,240...128,236,625
G
Fam187b
family with sequence similarity 187, member B
decreases expression
ISO
tebuconazole results in decreased expression of FAM187B mRNA
CTD
PMID:30458266
NCBI chr 1:95,329,482...95,346,940
Ensembl chr 1:95,332,631...95,371,536
G
Fasn
fatty acid synthase
increases expression multiple interactions
ISO
tebuconazole results in increased expression of FASN mRNA [propiconazole co-treated with tebuconazole] results in increased expression of FASN mRNA
CTD
PMID:30989312
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fcer1a
Fc epsilon receptor Ia
decreases expression
ISO
tebuconazole results in decreased expression of FCER1A mRNA
CTD
PMID:30458266
NCBI chr13:88,218,427...88,224,723
Ensembl chr13:88,218,420...88,224,681
G
Fgf5
fibroblast growth factor 5
decreases expression
ISO
tebuconazole results in decreased expression of FGF5 mRNA
CTD
PMID:30458266
NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,627,906...11,650,243
G
Fgfbp3
fibroblast growth factor binding protein 3
increases expression
EXP
tebuconazole results in increased expression of FGFBP3 mRNA
CTD
PMID:28970091
NCBI chr 1:244,056,569...244,058,574
Ensembl chr 1:244,056,307...244,065,654
G
Flna
filamin A
decreases expression
ISO
tebuconazole results in decreased expression of FLNA mRNA
CTD
PMID:30458266
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:157,159,051...157,182,343
G
Folr2
folate receptor beta
decreases expression
ISO
tebuconazole results in decreased expression of FOLR2 mRNA
CTD
PMID:30458266
NCBI chr 1:165,612,047...165,630,382
Ensembl chr 1:165,612,063...165,617,731
G
Frmpd2
FERM and PDZ domain containing 2
decreases expression
ISO
tebuconazole results in decreased expression of FRMPD2 mRNA
CTD
PMID:30458266
NCBI chr16:8,763,889...8,883,558
Ensembl chr16:8,763,956...8,883,551
G
Fscn1
fascin actin-bundling protein 1
decreases expression
ISO
tebuconazole results in decreased expression of FSCN1 mRNA
CTD
PMID:30458266
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
tebuconazole results in decreased expression of G6PC1 mRNA
CTD
PMID:30458266 PMID:32194361
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
G
Gabrp
gamma-aminobutyric acid type A receptor subunit pi
decreases expression
ISO
tebuconazole results in decreased expression of GABRP mRNA
CTD
PMID:30458266
NCBI chr10:18,647,243...18,673,806
Ensembl chr10:18,647,243...18,673,727
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
tebuconazole results in increased expression of GADD45B mRNA
CTD
PMID:25656644
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
G
Gfm1
G elongation factor, mitochondrial 1
increases expression
ISO
tebuconazole results in increased expression of GFM1 mRNA
CTD
PMID:30458266
NCBI chr 2:154,010,601...154,055,523
Ensembl chr 2:154,010,614...154,065,805
G
Ghrhr
growth hormone releasing hormone receptor
decreases expression
ISO
tebuconazole results in decreased expression of GHRHR mRNA
CTD
PMID:30458266
NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:85,830,486...85,863,127
G
Gnmt
glycine N-methyltransferase
decreases expression
ISO
tebuconazole results in decreased expression of GNMT mRNA
CTD
PMID:30458266
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
G
Gp9
glycoprotein IX (platelet)
decreases expression
ISO
tebuconazole results in decreased expression of GP9 mRNA
CTD
PMID:30458266
NCBI chr 4:121,792,842...121,794,452
Ensembl chr 4:121,792,653...121,794,475
G
Gpat2
glycerol-3-phosphate acyltransferase 2, mitochondrial
decreases expression
ISO
tebuconazole results in decreased expression of GPAT2 mRNA
CTD
PMID:30458266
NCBI chr 3:135,099,751...135,110,355
Ensembl chr 3:135,096,752...135,110,353
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of GPD1 mRNA tebuconazole results in increased expression of GPD1 mRNA
CTD
PMID:30989312
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
G
Gsr
glutathione-disulfide reductase
decreases activity
EXP
tebuconazole results in decreased activity of GSR protein
CTD
PMID:32735800
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
G
Gstm2
glutathione S-transferase mu 2
increases expression
ISO
tebuconazole results in increased expression of GSTM2 mRNA
CTD
PMID:30458266
NCBI chr 2:198,312,179...198,316,962
G
Guca1b
guanylate cyclase activator 1B
decreases expression
ISO
tebuconazole results in decreased expression of GUCA1B mRNA
CTD
PMID:30458266
NCBI chr 9:21,097,274...21,105,107
Ensembl chr 9:21,097,274...21,105,107
G
Hamp
hepcidin antimicrobial peptide
decreases expression
EXP
tebuconazole results in decreased expression of HAMP mRNA
CTD
PMID:33049508
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
G
Hba-a3
hemoglobin alpha, adult chain 3
decreases expression
ISO
tebuconazole results in decreased expression of HBA2 mRNA
CTD
PMID:30458266
NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,816,096...15,817,167
G
Hbb-b1
hemoglobin, beta adult major chain
decreases expression
ISO
tebuconazole results in decreased expression of HBD mRNA
CTD
PMID:30458266
NCBI chr 1:167,636,064...167,643,577
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
tebuconazole results in decreased expression of HBEGF mRNA
CTD
PMID:26852204
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
G
Hbg1
hemoglobin subunit gamma 1
decreases expression
ISO
tebuconazole results in decreased expression of HBG1 mRNA
CTD
PMID:30458266
NCBI chr 1:167,683,760...167,685,315
Ensembl chr 1:167,683,760...167,706,139
G
Hbq1b
hemoglobin subunit theta 1B
decreases expression
ISO
tebuconazole results in decreased expression of HBQ1 mRNA
CTD
PMID:30458266
NCBI chr10:15,838,752...15,840,074
Ensembl chr10:15,825,223...15,825,858
G
Hdc
histidine decarboxylase
decreases expression
ISO
tebuconazole results in decreased expression of HDC mRNA
CTD
PMID:30458266
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
G
Heph
hephaestin
decreases expression
ISO
tebuconazole results in decreased expression of HEPH mRNA
CTD
PMID:30458266
NCBI chr X:65,160,628...65,412,457
Ensembl chr X:65,305,773...65,412,453
G
Hils1
histone linker H1 domain, spermatid-specific 1
decreases expression
ISO
tebuconazole results in decreased expression of H1-9P mRNA
CTD
PMID:30458266
NCBI chr10:80,410,361...80,411,157
Ensembl chr10:80,399,812...80,411,157
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
tebuconazole results in increased expression of HMGCR mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
ISO
tebuconazole results in increased expression of HMGCS1 mRNA
CTD
PMID:36291160
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
decreases expression
ISO
tebuconazole results in decreased expression of HMGCS2 mRNA
CTD
PMID:30458266
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
G
Hmx1
H6 family homeobox 1
decreases expression
ISO
tebuconazole results in decreased expression of HMX1 mRNA
CTD
PMID:30458266
NCBI chr14:79,585,840...79,589,626
Ensembl chr14:79,585,840...79,589,626
G
Homer2
homer scaffold protein 2
decreases expression
ISO
tebuconazole results in decreased expression of HOMER2 mRNA
CTD
PMID:30458266
NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:144,976,436...145,068,997
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
ISO
tebuconazole results in increased expression of HSD17B7 mRNA
CTD
PMID:30458266
NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754
G
Htr2a
5-hydroxytryptamine receptor 2A
decreases expression
ISO
tebuconazole results in decreased expression of HTR2A mRNA
CTD
PMID:30458266
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619
G
Igsf3
immunoglobulin superfamily, member 3
decreases expression
ISO
tebuconazole results in decreased expression of IGSF3 mRNA
CTD
PMID:30458266
NCBI chr 2:191,499,972...191,588,249
Ensembl chr 2:191,500,045...191,588,249
G
Inhbe
inhibin subunit beta E
decreases expression
ISO
tebuconazole results in decreased expression of INHBE mRNA
CTD
PMID:30458266
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
G
Insig1
insulin induced gene 1
increases expression multiple interactions
ISO
tebuconazole results in increased expression of INSIG1 mRNA [propiconazole co-treated with tebuconazole] results in increased expression of INSIG1 mRNA
CTD
PMID:30458266 PMID:30989312
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
G
Irf6
interferon regulatory factor 6
decreases expression
ISO
tebuconazole results in decreased expression of IRF6 mRNA
CTD
PMID:30458266
NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049
G
Islr2
immunoglobulin superfamily containing leucine-rich repeat 2
decreases expression
ISO
tebuconazole results in decreased expression of ISLR2 mRNA
CTD
PMID:30458266
NCBI chr 8:67,504,042...67,512,125
Ensembl chr 8:67,504,037...67,513,708
G
Itgad
integrin subunit alpha D
decreases expression
ISO
tebuconazole results in decreased expression of ITGAD mRNA
CTD
PMID:30458266
NCBI chr 1:192,190,204...192,218,864
Ensembl chr 1:192,190,204...192,218,864
G
Jag1
jagged canonical Notch ligand 1
increases expression
EXP
tebuconazole results in increased expression of JAG1 mRNA; tebuconazole results in increased expression of JAG1 protein
CTD
PMID:33049508
NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872
G
Jag2
jagged canonical Notch ligand 2
decreases expression
ISO
tebuconazole results in decreased expression of JAG2 mRNA
CTD
PMID:30458266
NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738
G
Kcnk7
potassium two pore domain channel subfamily K member 7
decreases expression
ISO
tebuconazole results in decreased expression of KCNK7 mRNA
CTD
PMID:30458266
NCBI chr 1:212,419,555...212,422,173
Ensembl chr 1:212,419,555...212,422,566
G
Kdm2b
lysine demethylase 2B
decreases expression
ISO
tebuconazole results in decreased expression of KDM2B mRNA
CTD
PMID:30458266
NCBI chr12:39,224,422...39,362,126
Ensembl chr12:39,235,301...39,362,127
G
Kiaa0825
KIAA0825 homolog
decreases expression
ISO
tebuconazole results in decreased expression of KIAA0825 mRNA
CTD
PMID:30458266
NCBI chr 2:8,606,257...9,167,308
Ensembl chr 2:8,606,281...9,167,180
G
Kif17
kinesin family member 17
decreases expression
ISO
tebuconazole results in decreased expression of KIF17 mRNA
CTD
PMID:30458266
NCBI chr 5:155,765,592...155,802,941
Ensembl chr 5:155,765,592...155,803,247
G
Kif5a
kinesin family member 5A
decreases expression
ISO
tebuconazole results in decreased expression of KIF5A mRNA
CTD
PMID:30458266
NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:64,934,740...64,978,272
G
Kiz
kizuna centrosomal protein
decreases expression
ISO
tebuconazole results in decreased expression of KIZ mRNA
CTD
PMID:30458266
NCBI chr 3:154,730,873...154,838,410
Ensembl chr 3:154,730,634...154,838,410
G
Krtap3-1
keratin associated protein 3-1
decreases expression
ISO
tebuconazole results in decreased expression of KRTAP3-1 mRNA
CTD
PMID:30458266
NCBI chr10:85,023,843...85,024,139
Ensembl chr10:85,023,843...85,024,139
G
Lbh
LBH regulator of WNT signaling pathway
decreases expression
ISO
tebuconazole results in decreased expression of LBH mRNA
CTD
PMID:30458266
NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238
G
Lcn1
lipocalin 1
decreases expression
ISO
tebuconazole results in decreased expression of LCN1 mRNA
CTD
PMID:30458266
NCBI chr 3:29,930,943...29,935,418
G
Lctl
lactase-like
decreases expression
ISO
tebuconazole results in decreased expression of LCTL mRNA
CTD
PMID:30458266
NCBI chr 8:73,506,096...73,534,668
Ensembl chr 8:73,513,634...73,534,668
G
Lhx1
LIM homeobox 1
increases expression
EXP
tebuconazole results in increased expression of LHX1 mRNA
CTD
PMID:28970091
NCBI chr10:69,894,288...69,901,076
Ensembl chr10:69,894,288...69,901,076
G
Lilrb4
leukocyte immunoglobulin like receptor B4
decreases expression
ISO
tebuconazole results in decreased expression of LILRB4 mRNA
CTD
PMID:30458266
NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:78,847,685...78,853,326
G
Lrrc31
leucine rich repeat containing 31
decreases expression
ISO
tebuconazole results in decreased expression of LRRC31 mRNA
CTD
PMID:30458266
NCBI chr 2:114,624,177...114,654,909
Ensembl chr 2:114,631,136...114,652,269
G
Lrrc75a
leucine rich repeat containing 75A
increases expression
EXP
tebuconazole results in increased expression of LRRC75A mRNA
CTD
PMID:28970091
NCBI chr10:47,798,028...47,842,577
Ensembl chr10:47,798,028...47,842,577
G
Lrtomt
leucine rich transmembrane and O-methyltransferase domain containing
decreases expression
ISO
tebuconazole results in decreased expression of LRTOMT mRNA
CTD
PMID:30458266
NCBI chr 1:165,678,654...165,680,703
Ensembl chr 1:165,678,654...165,680,703
G
Lss
lanosterol synthase
increases expression
ISO
tebuconazole results in increased expression of LSS mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
G
Mab21l3
mab-21 like 3
decreases expression
ISO
tebuconazole results in decreased expression of MAB21L3 mRNA
CTD
PMID:30458266
NCBI chr 2:191,937,451...191,960,204
Ensembl chr 2:191,937,451...191,960,204
G
Mab21l4
mab-21 like 4
decreases expression
ISO
tebuconazole results in decreased expression of MAB21L4 mRNA
CTD
PMID:30458266
NCBI chr 9:101,138,408...101,148,516
Ensembl chr 9:101,138,408...101,147,915
G
Matn1
matrilin 1
decreases expression
ISO
tebuconazole results in decreased expression of MATN1 mRNA
CTD
PMID:30458266
NCBI chr 5:148,401,364...148,411,256
Ensembl chr 5:148,401,620...148,411,256
G
Mcf2l
MCF.2 cell line derived transforming sequence-like
decreases expression
ISO
tebuconazole results in decreased expression of MCF2L mRNA
CTD
PMID:30458266
NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956
G
Meg3
maternally expressed 3
decreases expression
ISO
tebuconazole results in decreased expression of MEG3 mRNA
CTD
PMID:30458266
NCBI chr 6:134,274,056...134,306,249
G
Mfap5
microfibril associated protein 5
decreases expression
ISO
tebuconazole results in decreased expression of MFAP5 mRNA
CTD
PMID:30458266
NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448
G
Miox
myo-inositol oxygenase
decreases expression
ISO
tebuconazole results in decreased expression of MIOX mRNA
CTD
PMID:30458266
NCBI chr 7:122,284,660...122,287,158
Ensembl chr 7:122,284,660...122,287,157
G
Mlxipl
MLX interacting protein-like
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of MLXIPL mRNA; [tebuconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA tebuconazole results in increased expression of MLXIPL mRNA
CTD
PMID:30989312 PMID:33575850
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
tebuconazole results in decreased expression of MMP2 mRNA
CTD
PMID:26852204
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Mmp21
matrix metallopeptidase 21
decreases expression
ISO
tebuconazole results in decreased expression of MMP21 mRNA
CTD
PMID:30458266
NCBI chr 1:197,910,178...197,915,847
Ensembl chr 1:197,910,178...197,915,847
G
Mmp9
matrix metallopeptidase 9
decreases expression
ISO
tebuconazole results in decreased expression of MMP9 mRNA
CTD
PMID:26852204
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Mrgpre
MAS related GPR family member E
decreases expression
ISO
tebuconazole results in decreased expression of MRGPRE mRNA
CTD
PMID:30458266
NCBI chr 1:208,393,141...208,401,252
Ensembl chr 1:208,392,642...208,399,408
G
Mro
maestro
decreases expression
ISO
tebuconazole results in decreased expression of MRO mRNA
CTD
PMID:30458266
NCBI chr18:69,723,764...69,742,815
Ensembl chr18:69,725,798...69,743,031
G
Msmo1
methylsterol monooxygenase 1
increases expression
EXP ISO
tebuconazole results in increased expression of MSMO1 mRNA
CTD
PMID:28970091 PMID:29337257 PMID:36291160
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445
G
Msx2
msh homeobox 2
decreases expression
ISO
tebuconazole results in decreased expression of MSX2 mRNA
CTD
PMID:30458266
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
G
Muc3a
mucin 3A, cell surface associated
decreases expression
ISO
tebuconazole results in decreased expression of MUC3A mRNA
CTD
PMID:30458266
NCBI chr12:25,082,728...25,091,494
Ensembl chr12:25,082,837...25,097,265
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
decreases expression
ISO
tebuconazole results in decreased expression of MUC5AC mRNA
CTD
PMID:30458266
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:206,293,869...206,326,006
G
Mvd
mevalonate diphosphate decarboxylase
increases expression
ISO
tebuconazole results in increased expression of MVD mRNA
CTD
PMID:30458266
NCBI chr19:67,404,911...67,414,974
Ensembl chr19:67,404,911...67,422,366
G
Myog
myogenin
decreases expression
ISO
tebuconazole results in decreased expression of MYOG mRNA
CTD
PMID:30458266
NCBI chr13:48,297,476...48,300,065
Ensembl chr13:48,297,235...48,300,065
G
Myrfl
myelin regulatory factor-like
decreases expression
ISO
tebuconazole results in decreased expression of MYRFL mRNA
CTD
PMID:30458266
NCBI chr 7:54,289,430...54,406,097
Ensembl chr 7:54,289,332...54,405,868
G
Ndnf
neuron-derived neurotrophic factor
increases expression
EXP
tebuconazole results in increased expression of NDNF mRNA
CTD
PMID:28970091
NCBI chr 4:96,274,147...96,311,624
Ensembl chr 4:96,274,147...96,311,624
G
Ngfr
nerve growth factor receptor
increases expression
EXP
tebuconazole results in increased expression of NGFR mRNA
CTD
PMID:28970091
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
G
Niban1
niban apoptosis regulator 1
decreases expression
ISO
tebuconazole results in decreased expression of NIBAN1 mRNA
CTD
PMID:30458266
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
G
Nid2
nidogen 2
decreases expression
ISO
tebuconazole results in decreased expression of NID2 mRNA
CTD
PMID:30458266
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949
G
Nphs2
NPHS2 stomatin family member, podocin
decreases expression
ISO
tebuconazole results in decreased expression of NPHS2 mRNA
CTD
PMID:30458266
NCBI chr13:70,993,622...71,011,585
Ensembl chr13:70,999,186...71,011,572
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity multiple interactions
ISO
tebuconazole results in increased activity of NR1I2 protein [tebuconazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; tebuconazole binds to and results in increased activity of NR1I2 protein
CTD
PMID:28728110 PMID:29420809 PMID:33049310 PMID:36291160
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
affects response to substance multiple interactions increases response to substance decreases expression decreases activity
ISO EXP
NR1I3 protein affects the susceptibility to tebuconazole NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP4A10 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of POR mRNA] NR1I3 results in increased susceptibility to tebuconazole tebuconazole binds to and results in decreased activity of NR1I3 protein [tebuconazole co-treated with fludioxonil] results in decreased expression of NR1I3 mRNA; tebuconazole binds to and results in decreased activity of NR1I3 protein tebuconazole results in decreased expression of NR1I3 mRNA tebuconazole results in decreased activity of NR1I3 protein
CTD
PMID:23721867 PMID:25656644 PMID:29420809 PMID:33575850 PMID:36291160
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
G
Nutm1
NUT midline carcinoma, family member 1
increases expression
ISO
tebuconazole results in increased expression of NUTM1 mRNA
CTD
PMID:30458266
NCBI chr 3:119,507,908...119,518,709
Ensembl chr 3:119,507,908...119,526,185
G
Obscn
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
decreases expression
ISO
tebuconazole results in decreased expression of OBSCN mRNA
CTD
PMID:30458266
NCBI chr10:44,273,686...44,419,275
Ensembl chr10:44,288,866...44,419,297
G
Odf4
outer dense fiber of sperm tails 4
decreases expression
ISO
tebuconazole results in decreased expression of ODF4 mRNA
CTD
PMID:30458266
NCBI chr10:54,127,398...54,133,227
Ensembl chr10:54,127,611...54,133,285
G
Oprl1
opioid related nociceptin receptor 1
decreases expression
ISO
tebuconazole results in decreased expression of OPRL1 mRNA
CTD
PMID:30458266
NCBI chr 3:189,209,495...189,225,406
Ensembl chr 3:189,212,175...189,217,426
G
Or10c1
olfactory receptor family 10 subfamily C member 1
decreases expression
ISO
tebuconazole results in decreased expression of OR10C1 mRNA
CTD
PMID:30458266
NCBI chr20:1,375,847...1,376,785
Ensembl chr20:1,375,847...1,376,785
G
Or2t1
olfactory receptor family 2 subfamily T member 1
decreases expression
ISO
tebuconazole results in decreased expression of OR2T1 mRNA
CTD
PMID:30458266
NCBI chr15:13,391,080...13,392,033
Ensembl chr15:13,391,080...13,392,033 Ensembl chr15:13,391,080...13,392,033
G
Or4d10c
olfactory receptor family 4 subfamily D member 10C
decreases expression
ISO
tebuconazole results in decreased expression of OR4D10 mRNA
CTD
PMID:30458266
NCBI chr 1:218,441,392...218,442,327
Ensembl chr 1:218,441,392...218,442,327
G
Pabpn1l
PABPN1 like
decreases expression
ISO
tebuconazole results in decreased expression of PABPN1L mRNA
CTD
PMID:30458266
NCBI chr19:67,578,494...67,581,938
Ensembl chr19:67,578,496...67,581,895
G
Pak1
p21 (RAC1) activated kinase 1
decreases expression
ISO
tebuconazole results in decreased expression of PAK1 mRNA
CTD
PMID:30458266
NCBI chr 1:161,522,399...161,637,623
Ensembl chr 1:161,491,847...161,637,612
G
Palld
palladin, cytoskeletal associated protein
decreases expression
ISO
tebuconazole results in decreased expression of PALLD mRNA
CTD
PMID:30458266
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232
G
Panx3
pannexin 3
decreases expression
ISO
tebuconazole results in decreased expression of PANX3 mRNA
CTD
PMID:30458266
NCBI chr 8:45,554,474...45,566,378
Ensembl chr 8:45,555,501...45,566,378
G
Pgf
placental growth factor
decreases expression
ISO
tebuconazole results in decreased expression of PGF mRNA
CTD
PMID:26852204
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
tebuconazole results in decreased expression of PLAU mRNA
CTD
PMID:26852204
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
G
Plekhg7
pleckstrin homology and RhoGEF domain containing G7
decreases expression
ISO
tebuconazole results in decreased expression of PLEKHG7 mRNA
CTD
PMID:30458266
NCBI chr 7:32,614,744...32,692,659
G
Pln
phospholamban
increases expression
EXP
tebuconazole results in increased expression of PLN mRNA
CTD
PMID:33049508
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
G
Pnliprp1
pancreatic lipase-related protein 1
decreases expression
ISO
tebuconazole results in decreased expression of PNLIPRP1 mRNA
CTD
PMID:30458266
NCBI chr 1:267,854,027...267,869,654
Ensembl chr 1:267,854,027...267,869,654
G
Por
cytochrome p450 oxidoreductase
increases expression multiple interactions
ISO
tebuconazole results in increased expression of POR mRNA NR1I3 promotes the reaction [tebuconazole results in increased expression of POR mRNA]
CTD
PMID:25656644
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
tebuconazole binds to and results in increased activity of PPARG protein
CTD
PMID:33049310
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Pramef8
PRAME family member 8
decreases expression
ISO
tebuconazole results in decreased expression of PRAMEF8 mRNA
CTD
PMID:30458266
NCBI chr 5:161,061,444...161,077,222
Ensembl chr 5:161,061,444...161,077,222
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
decreases expression
ISO
tebuconazole results in decreased expression of PRG2 mRNA
CTD
PMID:30458266
NCBI chr 3:90,469,192...90,472,759
Ensembl chr 3:90,469,176...90,472,752
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
multiple interactions
ISO
[tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA1 protein
CTD
PMID:30698772
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
multiple interactions
ISO
[tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein
CTD
PMID:30698772
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
G
Prss3
serine protease 3
decreases expression
ISO
tebuconazole results in decreased expression of PRSS3 mRNA
CTD
PMID:30458266
NCBI chr 4:71,169,749...71,173,223
Ensembl chr 4:71,169,749...71,173,223
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[tebuconazole binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2
CTD
PMID:26359731
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Ptprc
protein tyrosine phosphatase, receptor type, C
increases expression
ISO
tebuconazole results in increased expression of PTPRC mRNA
CTD
PMID:30458266
NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746
G
Purg
purine-rich element binding protein G
decreases expression
ISO
tebuconazole results in decreased expression of PURG mRNA
CTD
PMID:30458266
NCBI chr16:65,435,371...65,466,437
Ensembl chr16:65,412,238...65,466,185
G
Rai1
retinoic acid induced 1
decreases expression
ISO
tebuconazole results in decreased expression of RAI1 mRNA
CTD
PMID:30458266
NCBI chr10:45,412,748...45,507,747
Ensembl chr10:45,447,427...45,507,747
G
Rasal2
RAS protein activator like 2
decreases expression
ISO
tebuconazole results in decreased expression of RASAL2 mRNA
CTD
PMID:30458266
NCBI chr13:71,808,740...72,102,723
Ensembl chr13:71,813,261...72,102,723
G
Rasd1
ras related dexamethasone induced 1
increases expression
EXP
tebuconazole results in increased expression of RASD1 mRNA
CTD
PMID:28970091
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710
G
Ret
ret proto-oncogene
decreases expression
ISO
tebuconazole results in decreased expression of RET mRNA
CTD
PMID:30458266
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
tebuconazole results in decreased expression of RND1 mRNA
CTD
PMID:30458266
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
G
Rnf112
ring finger protein 112
increases expression
ISO
tebuconazole results in increased expression of RNF112 mRNA
CTD
PMID:30458266
NCBI chr10:46,620,602...46,655,745
Ensembl chr10:46,620,602...46,627,528
G
Rpp25
ribonuclease P and MRP subunit p25
decreases expression
ISO
tebuconazole results in decreased expression of RPP25 mRNA
CTD
PMID:30458266
NCBI chr 8:66,803,262...66,804,642
Ensembl chr 8:66,803,212...66,810,550
G
Rps6kl1
ribosomal protein S6 kinase-like 1
decreases expression
ISO
tebuconazole results in decreased expression of RPS6KL1 mRNA
CTD
PMID:30458266
NCBI chr 6:110,514,322...110,530,955
Ensembl chr 6:110,514,017...110,530,929
G
Rtp3
receptor (chemosensory) transporter protein 3
decreases expression
ISO
tebuconazole results in decreased expression of RTP3 mRNA
CTD
PMID:30458266
NCBI chr 8:119,847,947...119,853,549
Ensembl chr 8:119,848,556...119,853,095
G
Runx2
RUNX family transcription factor 2
decreases expression
ISO
tebuconazole results in decreased expression of RUNX2 mRNA
CTD
PMID:30458266
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
G
Sc5d
sterol-C5-desaturase
increases expression
EXP
tebuconazole results in increased expression of SC5D mRNA
CTD
PMID:28970091
NCBI chr 8:51,526,669...51,538,277
Ensembl chr 8:51,529,346...51,538,277
G
Scn4b
sodium voltage-gated channel beta subunit 4
decreases expression
ISO
tebuconazole results in decreased expression of SCN4B mRNA
CTD
PMID:30458266
NCBI chr 8:54,343,873...54,359,046
Ensembl chr 8:54,334,548...54,359,047
G
Scube1
signal peptide, CUB domain and EGF like domain containing 1
increases expression
EXP
tebuconazole results in increased expression of SCUBE1 mRNA
CTD
PMID:28970091
NCBI chr 7:116,639,027...116,760,986
Ensembl chr 7:116,642,231...116,760,944
G
Sec14l3
SEC14-like lipid binding 3
decreases expression
ISO
tebuconazole results in decreased expression of SEC14L3 mRNA
CTD
PMID:30458266
NCBI chr14:83,168,154...83,181,240
Ensembl chr14:83,168,208...83,179,654
G
Sele
selectin E
decreases expression
ISO
tebuconazole results in decreased expression of SELE mRNA
CTD
PMID:30458266
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
G
Serpine2
serpin family E member 2
increases expression
ISO
tebuconazole results in increased expression of SERPINE2 mRNA
CTD
PMID:26852204
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
G
Sh2d2a
SH2 domain containing 2A
decreases expression
ISO
tebuconazole results in decreased expression of SH2D2A mRNA
CTD
PMID:30458266
NCBI chr 2:175,610,127...175,616,685
Ensembl chr 2:175,609,874...175,616,685
G
Siglec10
sialic acid binding Ig-like lectin 10
decreases expression
ISO
tebuconazole results in decreased expression of SIGLEC10 mRNA
CTD
PMID:30458266
NCBI chr 1:102,953,894...102,962,964
Ensembl chr 1:102,953,918...102,962,964
G
Sla
src-like adaptor
increases expression
ISO
tebuconazole results in increased expression of SLA mRNA
CTD
PMID:30458266
NCBI chr 7:100,423,467...100,473,840
Ensembl chr 7:100,424,169...100,473,684
G
Slc10a1
solute carrier family 10 member 1
decreases expression
ISO
tebuconazole results in decreased expression of SLC10A1 mRNA
CTD
PMID:36291160
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc16a11
solute carrier family 16, member 11
decreases expression
ISO
tebuconazole results in decreased expression of SLC16A11 mRNA
CTD
PMID:30458266
NCBI chr10:55,427,773...55,431,678
Ensembl chr10:55,427,903...55,431,678
G
Slc22a15
solute carrier family 22, member 15
increases expression
ISO
tebuconazole results in increased expression of SLC22A15 mRNA
CTD
PMID:30458266
NCBI chr 2:191,987,409...192,049,859
Ensembl chr 2:191,987,409...192,047,362
G
Slc22a7
solute carrier family 22 member 7
decreases expression
ISO
tebuconazole results in decreased expression of SLC22A7 mRNA
CTD
PMID:30458266
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
G
Slc22a8
solute carrier family 22 member 8
decreases activity
ISO
tebuconazole results in decreased activity of SLC22A8 protein
CTD
PMID:36669674
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
decreases expression
ISO
tebuconazole results in decreased expression of SLC4A1 mRNA
CTD
PMID:30458266
NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,807,013...87,823,258
G
Slc51a
solute carrier family 51 member A
decreases expression
ISO
tebuconazole results in decreased expression of SLC51A mRNA
CTD
PMID:36291160
NCBI chr11:81,804,141...81,818,539
Ensembl chr11:81,803,972...81,818,539
G
Slc5a5
solute carrier family 5 member 5
decreases expression
ISO
tebuconazole results in decreased expression of SLC5A5 mRNA
CTD
PMID:30458266
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
G
Slc6a5
solute carrier family 6 member 5
decreases expression
ISO
tebuconazole results in decreased expression of SLC6A5 mRNA
CTD
PMID:30458266
NCBI chr 1:108,767,245...108,833,173
Ensembl chr 1:108,781,553...108,833,165
G
Slc9a1
solute carrier family 9 member A1
decreases expression
ISO
tebuconazole results in decreased expression of SLC9A1 mRNA
CTD
PMID:30458266
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
G
Slit1
slit guidance ligand 1
decreases expression
ISO
tebuconazole results in decreased expression of SLIT1 mRNA
CTD
PMID:30458266
NCBI chr 1:250,358,917...250,507,476
Ensembl chr 1:250,358,919...250,507,476
G
Smco1
single-pass membrane protein with coiled-coil domains 1
decreases expression
ISO
tebuconazole results in decreased expression of SMCO1 mRNA
CTD
PMID:30458266
NCBI chr11:82,017,142...82,020,025
Ensembl chr11:82,014,179...82,020,030
G
Snai1
snail family transcriptional repressor 1
increases expression
ISO
tebuconazole results in increased expression of SNAI1 mRNA
CTD
PMID:30458266
NCBI chr 3:176,667,476...176,671,965
G
Spdef
SAM pointed domain containing ets transcription factor
decreases expression
ISO
tebuconazole results in decreased expression of SPDEF mRNA
CTD
PMID:30458266
NCBI chr20:5,773,236...5,787,685
Ensembl chr20:5,773,231...5,787,689
G
Spi1
Spi-1 proto-oncogene
decreases expression
ISO
tebuconazole results in decreased expression of SPI1 mRNA
CTD
PMID:30458266
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:97,527,572...97,549,540
G
Sqle
squalene epoxidase
increases expression
ISO
tebuconazole results in increased expression of SQLE mRNA
CTD
PMID:30458266
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of SREBF1 mRNA tebuconazole results in increased expression of SREBF1 mRNA
CTD
PMID:30989312
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
decreases expression
ISO
tebuconazole results in decreased expression of SRMS mRNA
CTD
PMID:30458266
NCBI chr 3:188,696,070...188,702,474
Ensembl chr 3:188,696,071...188,702,474
G
Stum
stum, mechanosensory transduction mediator homolog
decreases expression
ISO
tebuconazole results in decreased expression of STUM mRNA
CTD
PMID:30458266
NCBI chr13:94,704,074...94,759,097
G
Sult1e1
sulfotransferase family 1E member 1
decreases expression
ISO
tebuconazole results in decreased expression of SULT1E1 mRNA
CTD
PMID:30458266
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,700,292...20,718,716
G
Syngap1
synaptic Ras GTPase activating protein 1
decreases expression
ISO
tebuconazole results in decreased expression of SYNGAP1 mRNA
CTD
PMID:30458266
NCBI chr20:5,028,226...5,058,519
Ensembl chr20:5,026,707...5,057,751
G
Tbx2
T-box transcription factor 2
decreases expression
ISO
tebuconazole results in decreased expression of TBX2 mRNA
CTD
PMID:30458266
NCBI chr10:71,177,082...71,186,275
Ensembl chr10:71,177,082...71,186,275
G
Tbx21
T-box transcription factor 21
increases expression
ISO
tebuconazole results in increased expression of TBX21 mRNA
CTD
PMID:30458266
NCBI chr10:82,578,751...82,595,253
Ensembl chr10:82,578,751...82,595,253
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
tebuconazole results in decreased expression of TERF1 mRNA
CTD
PMID:30458266
NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:8,226,345...8,255,753
G
Tex38
testis expressed 38
increases expression
ISO
tebuconazole results in increased expression of TEX38 mRNA
CTD
PMID:30458266
NCBI chr 5:134,498,309...134,502,352
Ensembl chr 5:134,497,501...134,503,041
G
Tfrc
transferrin receptor
decreases expression
EXP
tebuconazole results in decreased expression of TFRC mRNA; tebuconazole results in decreased expression of TFRC protein
CTD
PMID:33049508
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
ISO
tebuconazole results in increased expression of TICRR mRNA
CTD
PMID:30458266
NCBI chr 1:143,006,989...143,048,836
Ensembl chr 1:143,006,924...143,049,133
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
tebuconazole results in increased expression of TIMP1 mRNA
CTD
PMID:26852204
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
G
Timp2
TIMP metallopeptidase inhibitor 2
increases expression
ISO
tebuconazole results in increased expression of TIMP2 mRNA
CTD
PMID:26852204
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
G
Tm6sf2
transmembrane 6 superfamily member 2
decreases expression
ISO
tebuconazole results in decreased expression of TM6SF2 mRNA
CTD
PMID:30458266
NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,378,152...19,385,467
G
Tmed3
transmembrane p24 trafficking protein 3
decreases expression
ISO
tebuconazole results in decreased expression of TMED3 mRNA
CTD
PMID:30458266
NCBI chr 8:99,121,361...99,129,653
Ensembl chr 8:99,121,361...99,129,215
G
Tmem106b
transmembrane protein 106B
increases expression
ISO
tebuconazole results in increased expression of TMEM106B mRNA
CTD
PMID:30458266
NCBI chr 4:42,294,074...42,313,426
Ensembl chr 4:42,294,101...42,313,407
G
Tmem125
transmembrane protein 125
decreases expression
ISO
tebuconazole results in decreased expression of TMEM125 mRNA
CTD
PMID:30458266
NCBI chr 5:137,348,545...137,349,949
Ensembl chr 5:137,345,202...137,351,952
G
Tmem179
transmembrane protein 179
decreases expression
ISO
tebuconazole results in decreased expression of TMEM179 mRNA
CTD
PMID:30458266
NCBI chr 6:137,390,422...137,401,438
Ensembl chr 6:137,390,423...137,401,438
G
Tmem97
transmembrane protein 97
increases expression
ISO
tebuconazole results in increased expression of TMEM97 mRNA
CTD
PMID:30458266
NCBI chr10:63,936,276...63,945,359
Ensembl chr10:63,936,271...63,945,818
G
Tnf
tumor necrosis factor
decreases expression
ISO
tebuconazole results in decreased expression of TNF mRNA
CTD
PMID:26852204
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnni1
troponin I1, slow skeletal type
decreases expression
ISO
tebuconazole results in decreased expression of TNNI1 mRNA
CTD
PMID:30458266
NCBI chr13:49,781,529...49,793,385
Ensembl chr13:49,780,951...49,793,390
G
Tnnt3
troponin T3, fast skeletal type
decreases expression
ISO
tebuconazole results in decreased expression of TNNT3 mRNA
CTD
PMID:30458266
NCBI chr 1:207,082,014...207,099,014
Ensembl chr 1:207,081,812...207,099,423
G
Tnrc18
trinucleotide repeat containing 18
decreases expression
ISO
tebuconazole results in decreased expression of TNRC18 mRNA
CTD
PMID:30458266
NCBI chr12:16,868,930...16,965,224
Ensembl chr12:16,868,978...16,965,217
G
Tpbgl
trophoblast glycoprotein-like
decreases expression
ISO
tebuconazole results in decreased expression of TPBGL mRNA
CTD
PMID:30458266
NCBI chr 1:163,335,851...163,338,677
Ensembl chr 1:163,334,461...163,338,860
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
decreases expression
ISO
tebuconazole results in decreased expression of TRPV6 mRNA
CTD
PMID:30458266
NCBI chr 4:71,474,006...71,489,667
Ensembl chr 4:71,474,007...71,489,671
G
Tstd2
thiosulfate sulfurtransferase like domain containing 2
decreases expression
ISO
tebuconazole results in decreased expression of TSTD2 mRNA
CTD
PMID:30458266
NCBI chr 5:65,167,362...65,211,525
Ensembl chr 5:65,181,000...65,211,525
G
Txnl1
thioredoxin-like 1
decreases expression
ISO
tebuconazole results in decreased expression of TXNL1 mRNA
CTD
PMID:30458266
NCBI chr18:59,397,275...59,428,072
Ensembl chr18:59,398,535...59,435,518
G
Ubl4b
ubiquitin-like 4B
decreases expression
ISO
tebuconazole results in decreased expression of UBL4B mRNA
CTD
PMID:30458266
NCBI chr 2:197,880,669...197,883,167
Ensembl chr 2:197,878,322...197,882,005
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
decreases expression
ISO
tebuconazole results in decreased expression of UBR4 mRNA
CTD
PMID:30458266
NCBI chr 5:156,919,029...157,027,127
Ensembl chr 5:156,919,085...157,027,127
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
tebuconazole results in increased expression of UGT1A1 mRNA
CTD
PMID:30458266
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ulk1
unc-51 like autophagy activating kinase 1
multiple interactions
ISO
[tebuconazole co-treated with Econazole] results in increased phosphorylation of ULK1 protein; dorsomorphin inhibits the reaction [[tebuconazole co-treated with Econazole] results in increased phosphorylation of ULK1 protein]
CTD
PMID:30698772
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
G
Vegfc
vascular endothelial growth factor C
decreases expression
ISO
tebuconazole results in decreased expression of VEGFC mRNA
CTD
PMID:26852204
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
G
Wdr37
WD repeat domain 37
decreases expression
ISO
tebuconazole results in decreased expression of WDR37 mRNA
CTD
PMID:30458266
NCBI chr17:66,547,425...66,613,841
Ensembl chr17:66,547,147...66,613,841
G
Wdr38
WD repeat domain 38
decreases expression
ISO
tebuconazole results in decreased expression of WDR38 mRNA
CTD
PMID:30458266
NCBI chr 3:43,158,737...43,169,466
Ensembl chr 3:43,158,785...43,166,856
G
Wdr5b
WD repeat domain 5B
decreases expression
ISO
tebuconazole results in decreased expression of WDR5B mRNA
CTD
PMID:30458266
NCBI chr11:78,216,266...78,218,125
Ensembl chr11:78,190,355...78,218,501
G
Wfdc2
WAP four-disulfide core domain 2
decreases expression
ISO
tebuconazole results in decreased expression of WFDC2 mRNA
CTD
PMID:30458266
NCBI chr 3:173,706,091...173,735,055
Ensembl chr 3:173,706,460...173,712,161
G
Wnt1
Wnt family member 1
decreases expression
ISO
tebuconazole results in decreased expression of WNT1 mRNA
CTD
PMID:30458266
NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:131,817,558...131,821,605
G
Wnt10a
Wnt family member 10A
decreases expression
ISO
tebuconazole results in decreased expression of WNT10A mRNA
CTD
PMID:30458266
NCBI chr 9:83,798,594...83,811,060
Ensembl chr 9:83,798,594...83,811,067
G
Zfp7
zinc finger protein 7
decreases expression
ISO
tebuconazole results in decreased expression of ZNF7 mRNA
CTD
PMID:30458266
NCBI chr 7:110,479,387...110,499,552
Ensembl chr 7:110,488,156...110,501,660
G
Zg16
zymogen granule protein 16
decreases expression
ISO
tebuconazole results in decreased expression of ZG16 mRNA
CTD
PMID:30458266
NCBI chr 1:191,088,248...191,090,605
Ensembl chr 1:191,088,248...191,090,605
G
Znf568l-ps1
zinc finger protein 568 like, pseudogene 1
decreases expression
ISO
tebuconazole results in decreased expression of ZNF568 mRNA
CTD
PMID:30458266
NCBI chr 1:94,357,203...94,358,600
G
Zscan12
zinc finger and SCAN domain containing 12
decreases expression
ISO
tebuconazole results in decreased expression of ZSCAN12 mRNA
CTD
PMID:30458266
NCBI chr17:47,942,976...47,948,930
Ensembl chr17:47,942,977...47,964,605
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all